经尿道1470纳米半导体激光汽化术治疗前列腺增生的疗效分析

发布时间：2019-03-06 17:23

【摘要】：目的探讨经尿道1 470 nm半导体激光治疗前列腺增生(BPH)疗效和安全性。方法回顾性分析2015年12月-2016年4月该科应用1 470 nm半导体激光治疗BPH患者58例,观察其手术时间、手术前后血红蛋白、电解质和排尿情况等指标的变化。结果该组手术全部成功,平均手术时间(48.2±16.3)min,术后24 h内测定血红蛋白(Hb)、电解质比术前轻度下降,但差异无统计学意义(P0.05),随访1~3个月,国际前列腺症状评分(IPSS)、生活质量评分(QOL)、最大尿流率(Qmax)、残余尿量(PVR)较术前明显改善,差异有统计学意义(P0.05),无电切综合征、勃起功能障碍和尿失禁等发生。结论 1 470 nm半导体激光经尿道前列腺汽化术具有学习曲线短、术中出血极少和疗效确切等优点,应用前景广阔。
[Abstract]:Objective to evaluate the efficacy and safety of transurethral 1.470 nm semiconductor laser in the treatment of benign prostatic hyperplasia (BPH). Methods from December 2015 to April 2016, 58 patients with BPH were treated with 1 470 nm semiconductor laser. The changes of operation time, hemoglobin, electrolytes and urination were observed before and after operation. Results the mean operation time was (48.2 卤16.3) min, and the hemoglobin (Hb), electrolyte decreased slightly within 24 hours after operation, but there was no significant difference between the two groups (P0.05). The follow-up period was 1 month and 3 months, and the mean operative time was (48.2 卤16.3) h after operation. International prostate symptom score (IPSS), quality of life score (QOL), maximum urine flow rate (Qmax), residual urine volume (PVR) was significantly improved compared with pre-operation (P0.05), there was no electroresection syndrome, there was no significant difference between the two groups (P0.05). Erectile dysfunction and urinary incontinence occur. Conclusion Transurethral transurethral vaporization of prostate with 1 470 nm laser has the advantages of short learning curve, little intraoperative bleeding and definite curative effect.
【作者单位】：皖南医学院第二附属医院泌尿外科;
【基金】：皖南医学院重点培育基金(No:WK2016ZF10)
【分类号】：R699.8

【相似文献】